胸腺肽肠溶缓释片的研制及释放度的考察-- 关键词： 药剂学；缓释片；释放度；胸腺肽 [gap=1096]Key words: pharmaceutics ; sustained-release tablet ; release rate ; thymololypeptide
基于56个网页-相关网页
Cefaclor Sustained Release Tablet 头孢克洛缓释片
Nicardipine Hydrochloride Sustained Release Tablet 盐酸尼卡地平缓释片
Isosorbide Mononitrate Sustained Release Tablet 单硝酸异山梨酯缓释片
ph-independent sustained-release tablet 非ph依赖型缓释片
compound Danshen sustained-release tablet 复方丹参缓释片
Venlafaxine hydrochloride sustained-release tablet 博乐欣缓释片
Bioadhesion sustained-release tablet based on optimize prescription were prepared and studied through release experiment to investigate the stability of formulation and technics. The release data were analyzed with three models: Higuchi equation, zero order kinetics, and first order kinetics.
以优化处方制备的生物粘附缓释片,进行含量测定和释放度试验,考察制备工艺的稳定性,并将释放度数据分别用Higuchi模型,零级方程和一级方程进行拟合。
参考来源 - 格列吡嗪胃肠道生物粘附缓释片的研制Fitting the drug release mode by mathematical model according to the release data of Mizolastine sustained-release tablet, results show that drug release mode of Mizolastine sustained-release tablets meets Higuchi equation(C=42.722t1/2+3.5117,R=0.9969).
根据咪唑斯汀缓释片的释放数据,对其释药模式进行了数学模型拟合,结果表明,咪唑斯汀缓释片的释药模式符合Higuchi方程(C=42.722 t1/2+3.5117,R=0.9969)。
参考来源 - 咪唑斯汀缓释片的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
The new preparation is sustained-release tablet releasing medicaments slowly and inconstantly in a provided release medium.
该新剂型的特征在于本品为缓释片，在规定的释放介质中缓慢的非恒速的释放药物。
Objective: To study the quality specification of Gliclazide Sustained-release Tablet.
目的：对格列齐特缓释片进行质量标准研究。
CONCLUSION HPMC could be used as a matrix to prepare sustained-release tablet of ambroxol hydrochloride.
结论用羟丙甲基纤维素作为骨架材料能达到较好的缓释作用。
应用推荐